Multaq (Sanofi Winthrop Industries)


Welcome to the PulseAid listing for the Multaq drug offered from Sanofi Winthrop Industries. This Antiarrhythmic [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sanofi Winthrop Industries
NON-PROPRIETARY NAME: dronedarone
SUBSTANCE NAME: DRONEDARONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00


Multaq HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMultaq from Sanofi Winthrop Industries
LABELER NAME: Sanofi Winthrop Industries
DEA SCHEDULE:
ACTIVE STRENGTH: 400(mg/1)
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53360-4142_fecbdf4d-7761-4945-a23c-5edcc2ed0e4d
PRODUCT NDC: 53360-4142
APPLICATION NUMBER: NDA022425

Other DRONEDARONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthMultaq
Physicians Total Care, Inc.Multaq
Sanofi Winthrop IndustriesMultaq
sanofi-aventis U.S. LLCMultaq